Edition:
United States

Henan Lingrui Pharmaceutical Co Ltd (600285.SS)

600285.SS on Shanghai Stock Exchange

9.50CNY
23 Apr 2018
Change (% chg)

¥-0.06 (-0.63%)
Prev Close
¥9.56
Open
¥9.47
Day's High
¥9.75
Day's Low
¥9.42
Volume
4,725,195
Avg. Vol
6,510,654
52-wk High
¥12.52
52-wk Low
¥7.81

Chart for

About

Henan Lingrui Pharmaceutical Co., Ltd is a China-based company, principally engaged in the research and development, production and distribution of medicines. The Company's products include emplastrum, tablets, capsules, ointments and others, applied in the treatment of diabetes mellitus, osteoarthritis, gastropathy, cardiovascu... (more)

Overall

Beta: 0.83
Market Cap(Mil.): ¥5,678.83
Shares Outstanding(Mil.): 592.32
Dividend: 0.15
Yield (%): 3.15

Financials

  600285.SS Industry Sector
P/E (TTM): 28.40 30.21 32.78
EPS (TTM): 0.33 -- --
ROI: 8.97 13.61 13.21
ROE: 9.31 15.28 15.01

BRIEF-Henan Lingrui Pharmaceutical To Buy Back 300 Million Yuan Worth Of Company Shares

* SAYS IT PLANS TO BUY BACK 300 MILLION YUAN WORTH OF COMPANY SHARES AT UP TO 9 YUAN PER SHARE WITHIN SIX MONTHS Source text for Eikon: http://bit.ly/2E3CC1r Further company coverage: (Reporting by Hong Kong newsroom)

Feb 06 2018

BRIEF-Henan Lingrui Pharmaceutical passes review of high-tech enterprise recognition

* Says it passed the review of high-tech enterprise recognition and will enjoy a tax preference of 15 percent for three years

Dec 27 2017

BRIEF-Henan Lingrui Pharmaceutical unit obtains high-tech enterprise recognition

* Says its unit will enjoy tax preference of 15 percent for three years from Aug. 10

Dec 19 2017

Earnings vs. Estimates